Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1515-1520

  Egeter, Oliver ^a   Mocikat, Ralph ^a,b   Ghoreschi, Kamran ^a   Dieckmann, Andreas ^b   Röcken, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOMA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; COCULTURE TECHNIQUES; CPG ISLANDS; DNA; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS; TH1 CELLS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034653709     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boon, T., Cerottini, J. C., Van den Eynde, J. B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1998.
2. Pardoll, D. M. Cancer vaccines. Nat. Med., 5: 525-531, 1998.
3. Schuler, G., and Steinman, R. M. Dendritic cells as adjuvants for immune-mediated resistance to tumors J. Exp. Med., 186: 1183-1187, 1997.
4. Greenberg, P. D. Adoptive T cell therapy of tumors: mechanisms operative in the recognition, and elimination of tumor cells. Adv. Immunol., 49: 281-355, 1991.
5. Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., and Levitsky, H. The central role of CD4+ T-cells in the antitumor immune response. J. Exp. Med., 188: 2357-2368, 1998.
6. Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C. C., Carroll, M. W., Moss, B., Rosenberg, S. A., and Restifo, N. P. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA, 96: 2982-2987, 1999.
7. Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D., and Schreiber, H. CD4 T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ. Proc. Natl. Acad. Sci. USA, 96: 8633-8638, 1999.
8. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., and Rocken, M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med., 5. 1961-1966, 1994.
9. Schreiber, H. Tumor immunology. In: W. Paul (ed.). Fundamental Immunology, pp. 1137-1170. New York: Raven Press, Ltd., 1999.
10. Sotomayor, E. M., Borrello, I. Tubb, E., Rattis, F. M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., and Levitsky, H. I. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat. Med., 5: 780-787, 1999.
11. Wagner, H. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol., 73: 329-368, 1999.
12. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H., and Heeg, K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol., 160: 3627-3630, 1998.
13. Segal, B. M., Klinman, D. M., and Shevach, E. M. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol., 158: 5087-5090, 1997.
14. Mocikat, R., Selmayr, M., Thierfelder, S., and Lindhofer, H. Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity. Cancer Res., 57: 2346-2349, 1997.
15. Cherwinski, H. M., Schumacher, J. H., Brown, K. D., and Mosmann, T. R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med., 166: 1229-1244, 1987.
16. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA, 89: 6550-6554, 1992.
17. Ridge, J. P., Di Rosa, F., and Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (Lond.), 393: 474-478, 1998.
18. French, R. R., Chan, H. T., Tutt, A. L., and Glennie, M. J. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. Med., 5: 548-553, 1999.
19. Toes, R. E. M., Ossendorp, F., Offringa, R., and Melief, C. J. M. CD4 T cells and their role in antitumor immune responses. J. Exp. Med., 189: 753-756, 1999.
20. Grewal, I. S., and Flavell, R. A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol., 16: 111-135, 1998.
21. Abbas, A. K., Murphy, K. M., and Sher, A. Functional diversity of helper T lymphocytes. Nature (Lond.), 383: 787-793, 1996.
22. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F., and Heath, W. R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (Lond.), 393: 478-480, 1998.
23. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., and Melief, C. J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (Lond.), 393: 480-483, 1998.
24. Ye, X., McCarrick, J., Jewett, L., and Knowles, B. B. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice. Proc. Natl. Acad. Sci. USA, 91: 3916-3920, 1994.
25. Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., and Ohta, A. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in viva. J. Exp. Med., 190: 617-628, 1999.